In the current study, we confirmed that letrozole gavage administration could induce PCOS-like phenotypes in rats, including cystic ovarian morphology with a lack of corpora lutea, disturbance of the estrus cycle, and elevated testosterone levels and LH/FSH ratio. This evidence concerns the gene BRD2 and polycystic ovary syndrome.